Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 800

Sort by

Sort Order Select

Journal Articles

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Blood (2021) 138 (7): 571–583.

https://doi.org/10.1182/blood.2021010735

Published: 2021

Includes: Supplemental data

Journal Articles

Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism

Hannah Fassel, Huigen Chen, Mary Ruisi, Neha Kumar, Maria DeSancho, Katherine A. Hajjar

Blood (2021) 137 (16): 2221–2230.

https://doi.org/10.1182/blood.2020008123

Published: 2021

Includes: Supplemental data

Journal Articles

The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis

Manasa K. Nayak, Madankumar Ghatge, Gagan D. Flora, Nirav Dhanesha, Manish Jain, Kathleen R. Markan, Matthew J. Potthoff, Steven R. Lentz, Anil K. Chauhan

Blood (2021) 137 (12): 1658–1668.

https://doi.org/10.1182/blood.2020007140

Published: 2021

Includes: Supplemental data

Journal Articles

Structure of the platelet glycoprotein Ib receptor in complex with a novel antithrombotic agent

Jing Wang, Yongxiang Gao, Lan Chen, Yugang Guo, Siyi Hu, Liansheng Cheng, Weihua Xiao, Jiyuan Ke, Zhongliang Zhu, Liwen Niu

Blood (2021) 137 (6): 844–847.

https://doi.org/10.1182/blood.2020008028

Published: 2021

Includes: Supplemental data

Journal Articles

A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice

Adam Miszta, Anna K. Kopec, Asmita Pant, Lori A. Holle, James R. Byrnes, Daniel A. Lawrence, Kirk C. Hansen, Matthew J. Flick, James P. Luyendyk, Bas de Laat, Alisa S. Wolberg

Blood (2020) 135 (19): 1704–1717.

https://doi.org/10.1182/blood.2019004267

Published: 2020

Includes: Supplemental data

Journal Articles

The protein C activator AB002 rapidly interrupts thrombus development in baboons

Erik I. Tucker, Norah G. Verbout, Brandon D. Markway, Michael Wallisch, Christina U. Lorentz, Monica T. Hinds, Joseph J. Shatzel, Leslie A. Pelc, David C. Wood, Owen J. T. McCarty, Enrico Di Cera, András Gruber

Blood (2020) 135 (9): 689–699.

https://doi.org/10.1182/blood.2019002771

Published: 2020

Includes: Supplemental data

Journal Articles

Introduction to a review series on treatment of venous thrombotic disorders

Thomas L. Ortel

Blood (2020) 135 (5): 299–300.

https://doi.org/10.1182/blood.2019004079

Published: 2020

Journal Articles

Novel antithrombotic strategies for treatment of venous thromboembolism

Jeffrey I. Weitz, Noel C. Chan

Blood (2020) 135 (5): 351–359.

https://doi.org/10.1182/blood.2019000919

Published: 2020

Journal Articles

Treatment of unusual thrombotic manifestations

Maria Abbattista, Marco Capecchi, Ida Martinelli

Blood (2020) 135 (5): 326–334.

https://doi.org/10.1182/blood.2019000918

Published: 2020

Journal Articles

Monitoring the "Lifetime" of a Thrombus over Long Timescales By Leveraging a Novel Microvasculature-on-Chip Thrombosis Resolution Assay

Yongzhi Qiu, PhD, Yumiko Sakurai, MSc, Wilbur A. Lam, MD PhD

Blood (2019) 134 (Supplement_1): 441.

https://doi.org/10.1182/blood-2019-128718

Published: 2019

Journal Articles

Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN Registr

Marie Lindgren, Erik Ahlstrand, MD PhD, Helna Pettersson, MD, Maria Liljeholm, Anna Ravn-Landtblom, MD, Stefan Scheding, Prof, Björn Andréasson, MD PhD, Jan Samuelsson, MD PhD

Blood (2019) 134 (Supplement_1): 1658.

https://doi.org/10.1182/blood-2019-124374

Published: 2019

Journal Articles

TPA Use for Central Line De-Occlusion and Its Relationship to Symptomatic Venous Thromboembolism in Pediatric Leukemia Patients

Katherine Armstrong, MD, Kavitha Ramaswamy, MD, Victoria Cooley, MS, Linda M Gerber, PhD, Nicole Kucine, MD

Blood (2019) 134 (Supplement_1): 2111.

https://doi.org/10.1182/blood-2019-130315

Published: 2019

Journal Articles

Retrospective Review of Appropriate Use of Antimicrobials and Anticoagulants in Patients Hospitalized for a Malignant Hematologic Condition

Louis-Bassett Porter, MD, Hanaa Shihadeh, Kim Dittus, MD PhD

Blood (2019) 134 (Supplement_1): 2116.

https://doi.org/10.1182/blood-2019-121534

Published: 2019

Journal Articles

Effect of Sulfated NON-Anticoagulant Low Molecular Weight Heparin in Cancer and NON-Cancer Associated Thrombosis

Kavitha Godugu, PhD, Shymaa Mousa, Noureldien Hassan Elsayed Darwish, MDPhDBS, Shaker A Mousa, PhD BPharm, MBA, MSc

Blood (2019) 134 (Supplement_1): 3670.

https://doi.org/10.1182/blood-2019-130992

Published: 2019

Journal Articles

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Jeremy Y Feng, MD, Charles B Ross, MD FACS, FSVS, Rachel P Rosovsky, MDMPH

Blood (2019) 134 (Supplement_1): 3409.

https://doi.org/10.1182/blood-2019-125493

Published: 2019

Journal Articles

Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies

Jeffrey Laurence, MD, Sonia Elhadad, PhD

Blood (2019) 134 (Supplement_1): 3676.

https://doi.org/10.1182/blood-2019-124158

Published: 2019

Journal Articles

A Novel Platelet-Targeting Fibrinolytic Strategy: Endocytosed Urokinase By Megakaryocytes Is Stored in α-Granules and Is Functional In Vivo in a Murine Model of Thrombosis

Hyunsook Ahn, MSc, John Tkaczynski, BS, Khalil Bdeir, PhD, Victoria Stepanova, Douglas B. Cines, MD, Mortimer Poncz, MD, Sergei Zaitsev

Blood (2019) 134 (Supplement_1): 3627.

https://doi.org/10.1182/blood-2019-124501

Published: 2019

Journal Articles

Similar Hemostatic Responses to Hypovolemia in Hemorrhage and Lbnp Reveals a Hyperfibrinolytic Subset of Baboons

Maryanne Herzig, PhD, Morten Zaar, PhD, Chriselda Fedyk, Bijaya Kumar Parida, PhD, Carmen Hinojosa-Laborde, PhD, Robert E Shade, PhD, Heather F. Pidcoke, MD PhD, Victor A Convertion, PhD, Andrew P. Cap, MD PhD

Blood (2019) 134 (Supplement_1): 3633.

https://doi.org/10.1182/blood-2019-131792

Published: 2019

Journal Articles

Change in Admission Rates Among Patients Presenting to Emergency Departments with VTE and Low Risk of Complications: A Retrospective Cohort Study from 11 Community Hospitals

William Rhoades, DO, Rasha Khatib, PhD, Kara Nitti, MPH, Marc McDowell, PharmD, BCPS, Rick Szymialis, RPh, Christopher Blair, MS, BA, CCRP

Blood (2019) 134 (Supplement_1): 4694.

https://doi.org/10.1182/blood-2019-126844

Published: 2019

Journal Articles

Global Fibrinolysis Analysed By Clofal Method Is Not Associated with Post-Thrombotic Syndrome or Presence of Residual Vein Thrombosis in Patients with DVT in the Chronic Phase

Beatriz Moraes Martinelli, BSc, Stephany Cares Huber, PhD, Isabella Macedo Toni, MSc, Gabriela G Yamaguti-Hayakawa, MD, Gabriele Silva Souza Gois, Silmara Aparecida De Lima Montalvão, PhD, Joyce Maria Annichino- Bizzacchi, MD PhD

Blood (2019) 134 (Supplement_1): 2403.

https://doi.org/10.1182/blood-2019-131928

Published: 2019

NARROW

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism

The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis

Structure of the platelet glycoprotein Ib receptor in complex with a novel antithrombotic agent

A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice

The protein C activator AB002 rapidly interrupts thrombus development in baboons

Introduction to a review series on treatment of venous thrombotic disorders

Novel antithrombotic strategies for treatment of venous thromboembolism

Treatment of unusual thrombotic manifestations

Monitoring the "Lifetime" of a Thrombus over Long Timescales By Leveraging a Novel Microvasculature-on-Chip Thrombosis Resolution Assay

Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN Registr

TPA Use for Central Line De-Occlusion and Its Relationship to Symptomatic Venous Thromboembolism in Pediatric Leukemia Patients

Retrospective Review of Appropriate Use of Antimicrobials and Anticoagulants in Patients Hospitalized for a Malignant Hematologic Condition

Effect of Sulfated NON-Anticoagulant Low Molecular Weight Heparin in Cancer and NON-Cancer Associated Thrombosis

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies

A Novel Platelet-Targeting Fibrinolytic Strategy: Endocytosed Urokinase By Megakaryocytes Is Stored in α-Granules and Is Functional In Vivo in a Murine Model of Thrombosis

Similar Hemostatic Responses to Hypovolemia in Hemorrhage and Lbnp Reveals a Hyperfibrinolytic Subset of Baboons

Change in Admission Rates Among Patients Presenting to Emergency Departments with VTE and Low Risk of Complications: A Retrospective Cohort Study from 11 Community Hospitals

Global Fibrinolysis Analysed By Clofal Method Is Not Associated with Post-Thrombotic Syndrome or Presence of Residual Vein Thrombosis in Patients with DVT in the Chronic Phase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only